Sample size considerations in the design of cluster randomized trials of combination HIV prevention

被引:20
|
作者
Wang, Rui [1 ,2 ]
Goyal, Ravi [3 ]
Lei, Quanhong [3 ]
Essex, M. [4 ]
De Gruttola, Victor [3 ]
机构
[1] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Dept Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, Dept Neurol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
SUBTYPE C INFECTION; VIRAL LOAD; TRANSMISSION; INTERVENTIONS; AFRICA;
D O I
10.1177/1740774514523351
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Cluster randomized trials have been utilized to evaluate the effectiveness of HIV prevention strategies on reducing incidence. Design of such studies must take into account possible correlation of outcomes within randomized units. Purpose To discuss power and sample size considerations for cluster randomized trials of combination HIV prevention, using an HIV prevention study in Botswana as an illustration. Methods We introduce a new agent-based model to simulate the community-level impact of a combination prevention strategy and investigate how correlation structure within a community affects the coefficient of variation - an essential parameter in designing a cluster randomized trial. Results We construct collections of sexual networks and then propagate HIV on them to simulate the disease epidemic. Increasing level of sexual mixing between intervention and standard-of-care (SOC) communities reduces the difference in cumulative incidence in the two sets of communities. Fifteen clusters per arm and 500 incidence cohort members per community provide 95% power to detect the projected difference in cumulative HIV incidence between SOC and intervention communities (3.93% and 2.34%) at the end of the third study year, using a coefficient of variation 0.25. Although available formulas for calculating sample size for cluster randomized trials can be derived by assuming an exchangeable correlation structure within clusters, we show that deviations from this assumption do not generally affect the validity of such formulas. Limitations We construct sexual networks based on data from Likoma Island, Malawi, and base disease progression on longitudinal estimates from an incidence cohort in Botswana and in Durban as well as a household survey in Mochudi, Botswana. Network data from Botswana and larger sample sizes to estimate rates of disease progression would be useful in assessing the robustness of our model results. Conclusion Epidemic modeling plays a critical role in planning and evaluating interventions for prevention. Simulation studies allow us to take into consideration available information on sexual network characteristics, such as mixing within and between communities as well as coverage levels for different prevention modalities in the combination prevention package.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 50 条
  • [41] A flexible sample size solution for longitudinal and crossover cluster randomized trials with continuous outcomes
    Wang, Jijia
    Cao, Jing
    Zhang, Song
    Ahn, Chul
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [42] Sample size estimation in cluster randomized studies with varying cluster size
    Manatunga, AK
    Hudgens, MG
    Chen, SD
    BIOMETRICAL JOURNAL, 2001, 43 (01) : 75 - 86
  • [43] A note on the use of the variance inflation factor for determining sample size in cluster randomized trials
    Ukoumunne, OC
    Gulliford, MC
    Chinn, S
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 2002, 51 : 479 - 484
  • [44] Stepped wedge designs could reduce the required sample size in cluster randomized trials
    Woertman, Willem
    de Hoop, Esther
    Moerbeek, Mirjam
    Zuidema, Sytse U.
    Gerritsen, Debby L.
    Teerenstra, Steven
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (07) : 752 - 758
  • [45] Sample size estimation for modified Poisson analysis of cluster randomized trials with a binary outcome
    Li, Fan
    Tong, Guangyu
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (05) : 1288 - 1305
  • [46] Impact of Subject Attrition on Sample Size Determinations for Longitudinal Cluster Randomized Clinical Trials
    Heo, Moonseong
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (03) : 507 - 522
  • [47] Sample Size Issues for Cluster Randomized Trials With Discrete-Time Survival Endpoints
    Moerbeek, Mirjam
    METHODOLOGY-EUROPEAN JOURNAL OF RESEARCH METHODS FOR THE BEHAVIORAL AND SOCIAL SCIENCES, 2012, 8 (04) : 146 - 158
  • [48] Sample size calculation for cluster randomized trials with zero-inflated count outcomes
    Zhou, Zhengyang
    Li, Dateng
    Zhang, Song
    STATISTICS IN MEDICINE, 2022, 41 (12) : 2191 - 2204
  • [49] Statistical Power and Sample Size Requirements for Three Level Hierarchical Cluster Randomized Trials
    Heo, Moonseong
    Leon, Andrew C.
    BIOMETRICS, 2008, 64 (04) : 1256 - 1262
  • [50] Ethical considerations for new HIV prevention trials
    Sugarman, Jeremy
    Celum, Connie L.
    Donnell, Deborah
    Mayer, Kenneth H.
    LANCET HIV, 2019, 6 (08): : E489 - E491